Aclaris Therapeutics (ACRS) Reports $1.36M Stock Sale by Insider
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowLeonard Braden Michael sold $1.36 million worth of stock in Aclaris Therapeutics (ACRS). This transaction adds to the ongoing scrutiny of insider trading activities at the company. The sale signifies potential shifts in the company's stock sensitivity to insider activities, which can influence investor sentiment. The impact of such insider sales on market perceptions often varies and depends on the overall performance and outlook of Aclaris Therapeutics.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
TSX Stocks Recommended After Carney’s Investing Summit
Oct 26
SoFi Technologies (SOFI) Growth Strong but Rate Sensitivity Dampens Outlook
Oct 26
Shock Lula Win Derails $6 Billion Equity Sales Impacting Banks
Oct 26
Tesla (TSLA) Implied Price Estimated Between $355 and $372 Excluding SpaceX Deal
Oct 26